Twist Bioscience Corporation
NASDAQTwist Bioscience heads into the aftermath of its August 3 earnings print with a sharp post-results rally running headlong into one of the most stubborn short positions in biotech. The stock jumped 8.6% on the day of results, closing Tuesday at $99.45 after a 12.3% gain on the week. That move cuts against a short base that has barely budged. Short interest remains at 23.5% of free…
Snapshot as of 9 Aug 2026
Twist Bioscience heads into the aftermath of its August 3 earnings print with a sharp post-results rally running headlong into one of the most stubborn short positions in biotech. The stock jumped 8.6% on the day of…
Twist Bioscience enters the week with the Street aggressively revising upward, even as a 40% one-month rally has already run well past most of those fresh targets. The analyst angle is the defining tension right now.…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TWST — free to start on ORTEX.
Sign up for free →Open TWST on ORTEX